Search Results - Ananthakrishnan, Kameswari

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Therapeutic potential of a bi‐functional GLP‐1/Glibenclamide targeted to the pancreatic β‐cell

    Therapeutic potential of a bi‐functional GLP‐1/Glibenclamide targeted to the pancreatic β‐cell by Hart, Nathaniel, Vagner, Josef, Weber, Craig, Ananthakrishnan, Kameswari, Limesand, Sean

    Published in The FASEB journal
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    GLP‐1 linked to an α2‐adrenergic antagonist enhances glucose disposal (1108.2)

    GLP‐1 linked to an α2‐adrenergic antagonist enhances glucose disposal (1108.2) by Stein, Lauren, Yosten, Gina, Ananthakrishnan, Kameswari, Wagner, Josef, Lynch, Ronald, Samson, Willis

    Published in The FASEB journal
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Targeting glucagon‐like peptide‐1 and α2 adrenergic receptor combination using GLP‐1/yohimbine to achieve β‐cell specific targeting and therapy (1095.19)

    Targeting glucagon‐like peptide‐1 and α2 adrenergic receptor combination using GLP‐1/yohimbine to achieve β‐cell specific targeting and therapy (1095.19) by Ananthakrishnan, Kameswari, Weber, Craig, Hart, Nathaniel, Vagner, Josef, Limesand, Sean, Lynch, Ronald

    Published in The FASEB journal
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Specific targeting of pancreatic β‐cells by simultaneous binding of GLP‐1 and α2‐adrenergic receptors with a multivalent ligand

    Specific targeting of pancreatic β‐cells by simultaneous binding of GLP‐1 and α2‐adrenergic receptors with a multivalent ligand by Ananthakrishnan, Kameswari, Weber, Craig, Hart, Nathaniel, Vagner, Josef, Limesand, Sean, Lynch, Ronald

    Published in The FASEB journal
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    A Synthetic Heterobivalent Ligand Composed of Glucagon-Like Peptide 1 and Yohimbine Specifically Targets [beta] Cells Within the Pancreas

    A Synthetic Heterobivalent Ligand Composed of Glucagon-Like Peptide 1 and Yohimbine Specifically Targets [beta] Cells Within the Pancreas by Steyn, Leah V, Ananthakrishnan, Kameswari, Anderson, Miranda J, Patek, Renata, Kelly, Amy, Vagner, Josef, Lynch, Ronald M, Limesand, Sean W

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Multivalent GLP‐1/Yhb for targeted therapy and imaging of pancreatic β‐cells

    Multivalent GLP‐1/Yhb for targeted therapy and imaging of pancreatic β‐cells by Ananthakrishnan, Kameswari, Penrod, Leah V., Hart, Nathaniel J., Weber, Craig S., Anderson, Miranda, Vagner, Josef, Limesand, Sean W., Lynch, Ronald M.

    Published in The FASEB journal
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    TARGETING DIABETES: HIGH SPECIFICITY BINDING OF A YOHIMBINE LINKED GLP‐1 DIVALENT LIGAND TO PANCREATIC B‐CELLS

    TARGETING DIABETES: HIGH SPECIFICITY BINDING OF A YOHIMBINE LINKED GLP‐1 DIVALENT LIGAND TO PANCREATIC B‐CELLS by Ananthakrishnan, Kameswari, Weber, Craig S, Hart, Nathaniel, Vagner, Josef, Limesand, Sean, Lynch, Ronald M

    Published in The FASEB journal
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Hetero-bivalent GLP-1/Glibenclamide for Targeting Pancreatic [beta]-Cells

    Hetero-bivalent GLP-1/Glibenclamide for Targeting Pancreatic [beta]-Cells by Hart, Nathaniel J, Chung, Woo Jin, Weber, Craig, Ananthakrishnan, Kameswari, Anderson, Miranda, Patek, Renata, Zhang, Zhanyu, Limesand, Sean W, Vagner, Josef, Lynch, Ronald M

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Hetero-bivalent GLP-1/Glibenclamide for Targeting Pancreatic β-Cells

    Hetero-bivalent GLP-1/Glibenclamide for Targeting Pancreatic β-Cells by Hart, Nathaniel J., Chung, Woo Jin, Weber, Craig, Ananthakrishnan, Kameswari, Anderson, Miranda, Patek, Renata, Zhang, Zhanyu, Limesand, Sean W., Vagner, Josef, Lynch, Ronald M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  10. 10
    Heterobivalent GLP-1/Glibenclamide for Targeting Pancreatic β-cells

    Heterobivalent GLP-1/Glibenclamide for Targeting Pancreatic β-cells by Hart, Nathaniel J., Chung, Woo Jin, Weber, Craig, Ananthakrishnan, Kameswari, Anderson, Miranda, Patek, Renata, Zhang, Zhanyu, Limesand, Sean W., Vagner, Josef, Lynch, Ronald M.

    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    A Synthetic Heterobivalent Ligand Composed of Glucagon-Like Peptide 1 and Yohimbine Specifically Targets β Cells Within the Pancreas

    A Synthetic Heterobivalent Ligand Composed of Glucagon-Like Peptide 1 and Yohimbine Specifically Targets β Cells Within the Pancreas by Steyn, Leah V., Ananthakrishnan, Kameswari, Anderson, Miranda J., Patek, Renata, Kelly, Amy, Vagner, Josef, Lynch, Ronald M., Limesand, Sean W.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: